EAGER: Compact Field Portable Biophotonics Instrument for Real-Time Automated Analysis and Identification of Blood Cells Impact Impacted by COVID-19

EAGER：紧凑型现场便携式生物光子学仪器，用于实时自动分析和识别受 COVID-19 影响的血细胞

• 批准号: 2141473
• 负责人: Bahram Javidi
• 金额: $ 22万
• 依托单位: University of Connecticut
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2025-08-31
• 项目状态: 未结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2141473&HistoricalAwards=false
• 关键词: EAGER; Compact; Field; Portable; Biophotonics

COVID-19 pandemic quickly overwhelmed the healthcare resources in even advanced economies with large scale global fatalities not seen since the Spanish Flu of 1918. This project intends to investigate the impact of the COVID-19 virus on human red blood cells using an automated low-cost, field portable bio-photonics instrument. These studies can lead to better understanding of the impacted blood cells and precise measurement of cell anomalies for potential early detection of COVID-19. Accurate, rapid, and low-cost analysis and diagnosis of COVID-19 from blood cells with a compact field portable bio-photonics instrument interfaced with mobile devices will be a substantial advance toward widespread testing, medical diagnosis, early detection, disease prevention, and relevant data collection, particularly in remote areas without access to dedicated healthcare facilities. The proposed cross disciplinary project is based on a transformative biophotonics sensing approach for real-time analysis and disease detection and offers an alternative to conventional labor- and resource- intensive bio-molecular approaches. This analysis and capability would enable medical researchers to study and gain increased understanding of the effects of COVID-19 infections on blood cells. The proposed approach may provide a fast and reliable testing mechanism with the potential for widespread deployment, which is critical in dealing with pandemics, such as COVID-19, with high rates of infection and mortality. The success of the proposed approach would allow for automated low cost, rapid and highly accurate assessment of the impact of COVID-19 on blood cells, which is not currently possible using conventional methods. The proposed research provides new capabilities and benefits including real-time sensing and diagnosis; early detection with high accuracy, specificity, and sensitivity, and low cost field portable deployment in under resourced healthcare systems for real-time monitoring of pandemics.Investigating the impact of COVID-19 on blood cells and making detailed real-time measurements of the COVID-19 induced changes and anomalies of the blood cells at sub-micron scales would provide valuable research insights to fight COVID-19 and future pandemics. The proposed approach employs computational multi-dimensional sensing and imaging at sub-micron scales to analyze morphology and motility of blood cells. Specially embedded algorithms are integrated with mobile devices to analyze opto-biological signatures of blood cells in real time to find potential clues to the impact and presence of COVID-19 for rapid (real-time) COVID analysis and detection. The measurements and analysis of the infected cells will be performed at sub-micron scale lateral resolution and nano scale longitudinal resolution. The proposed project investigates blood cells morphology and temporal motility quantitatively with high precision using high resolution self-referencing digital holographic in compact 3D-printed platforms. Multidimensional bio-optical signature data, including spatial structure, refractive index, stiffness, and dynamic temporal behavior of the blood cells will be investigated to understand the influence of COVID-19 in blood cells. The use of dedicated machine learning algorithms associated with the analysis of anomalies in blood cells due to COVID-19 are intended to produce accurate detection and analysis.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

2019冠状病毒病大流行迅速使发达经济体的医疗资源不堪重负，自1918年西班牙流感以来从未出现过大规模的全球死亡人数。该项目旨在使用自动化低成本，现场便携式生物光子仪器来研究COVID-19病毒对人类红细胞的影响。这些研究可以更好地了解受影响的血细胞，并精确测量细胞异常，以便早期发现COVID-19。使用与移动的设备接口的紧凑型现场便携式生物光子仪器从血细胞中准确、快速和低成本地分析和诊断COVID-19，将是对广泛测试、医疗诊断、早期检测、疾病预防和相关数据收集的重大进步，特别是在无法获得专门医疗设施的偏远地区。拟议的跨学科项目基于一种用于实时分析和疾病检测的变革性生物光子传感方法，并为传统的劳动和资源密集型生物分子方法提供了替代方案。这种分析和能力将使医学研究人员能够研究和更多地了解COVID-19感染对血细胞的影响。所提出的方法可以提供一种快速可靠的测试机制，具有广泛部署的潜力，这对于应对感染率和死亡率高的COVID-19等大流行病至关重要。所提出的方法的成功将允许自动化低成本，快速和高度准确地评估COVID-19对血细胞的影响，这是目前使用传统方法无法实现的。拟议的研究提供了新的能力和好处，包括实时传感和诊断;具有高准确性、特异性和灵敏度的早期检测，在资源不足的医疗保健系统中进行低成本的现场便携式部署，以实时监测流行病。调查COVID-19对血细胞的影响，并对COVID-19引起的血细胞变化和异常进行详细的实时测量，微米尺度将为抗击COVID-19和未来的大流行病提供有价值的研究见解。所提出的方法采用计算多维传感和成像在亚微米尺度上分析血细胞的形态和运动。特别嵌入式算法与移动的设备集成，以真实的时间分析血细胞的光生物特征，以找到COVID-19的影响和存在的潜在线索，用于快速（实时）COVID分析和检测。感染细胞的测量和分析将以亚微米尺度的横向分辨率和纳米尺度的纵向分辨率进行。该项目利用紧凑型3D打印平台中的高分辨率自参考数字全息技术，高精度地定量研究血细胞形态和时间运动。将研究多维生物光学特征数据，包括血细胞的空间结构、折射率、刚度和动态时间行为，以了解COVID-19对血细胞的影响。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

项目成果

Generalization of the two-point-source resolution criterion in the presence of noise

存在噪声时两点源分辨率准则的推广

• DOI: 10.1364/ol.494910
• 发表时间: 2023
• 期刊: Optics Letters
• 影响因子: 3.6
• 作者: Wani, Pranav;Usmani, Kashif;Javidi, Bahram
• 通讯作者: Javidi, Bahram

Assessment of lateral resolution of single random phase encoded lensless imaging systems

单随机相位编码无透镜成像系统的横向分辨率评估

• DOI: 10.1364/oe.480591
• 发表时间: 2023
• 期刊: Optics Express
• 影响因子: 3.8
• 作者: Goswami, Saurabh;Wani, Pranav;Gupta, Gaurav;Javidi, Bahram
• 通讯作者: Javidi, Bahram